Control in Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Control in Clinical Trials in Brazil

Control in Clinical Trials in Brazil – Clinical Trials Landscape

Clinical trials serve as a crucial pillar of medical research, driving advancements in healthcare and improving patient outcomes. To ensure the reliability and ethical conduct of these trials, stringent control measures are essential.

This blog delves into the topic of control in clinical trials conducted in Brazil, shedding light on the key aspects that contribute to their integrity. We will explore the regulatory bodies involved, participant recruitment strategies, data monitoring practices, and ethical considerations, highlighting Brazil’s commitment to maintaining high standards in medical research.

Regulatory Bodies

Brazil has a well-established regulatory framework for clinical trials overseen by the National Health Surveillance Agency (ANVISA). ANVISA ensures compliance with national regulations and international guidelines such as Good Clinical Practice (GCP) and the Declaration of Helsinki.

The agency evaluates trial protocols, assesses the scientific validity, and ensures the protection of participant rights and welfare. ANVISA’s meticulous review process plays a crucial role in maintaining the integrity and ethical conduct of clinical trials in Brazil.

Participant Recruitment

Control in clinical trials begins with the recruitment of suitable participants. In Brazil, strict guidelines are followed to ensure transparency, diversity, and ethical practices in participant recruitment. Eligibility criteria are defined to identify individuals who meet specific health conditions, demographics, and trial requirements. Informed consent, emphasizing the trial’s purpose, potential risks, and benefits, is obtained from each participant.

Furthermore, Brazil emphasizes the inclusion of underrepresented populations, such as women, minorities, and individuals from different socio-economic backgrounds, to ensure the applicability and generalizability of trial outcomes. This commitment to diversity strengthens the scientific validity of clinical trials conducted in the country.

Data Monitoring

To maintain control and reliability, clinical trial data is continuously monitored. Independent Data Monitoring Committees (DMCs) or Data and Safety Monitoring Boards (DSMBs) are typically established to review trial progress and ensure participant safety.

These committees comprise experts who periodically review the trial data, confirm adherence to protocols, assess safety and efficacy, and make recommendations based on their findings. The data monitoring practices in Brazil play a critical role in ensuring accurate and trustworthy clinical trial outcomes.

Control in Clinical Trials in Brazil

Control in Clinical Trials in Brazil

Control in Clinical Trials in Brazil

Ethical Considerations

Ethics is of utmost importance in clinical trials conducted in Brazil. Before initiating a trial, researchers and sponsors must obtain ethical approvals from Institutional Review Boards (IRBs) or Ethics Committees (ECs). These committees carefully evaluate trial designs, participant recruitment procedures, informed consent processes, and risk-benefit assessments. They prioritize participant welfare, ensuring that their rights, safety, and privacy are protected throughout the trial.

Additionally, Brazil has regulations in place to prevent conflicts of interest and biases among investigators, sponsors, and trial sites. Transparent disclosure of financial relationships and potential conflicts of interest is required, promoting objectivity and maintaining trial integrity. These ethical considerations not only protect participants but also contribute to the credibility and trustworthiness of clinical research conducted in Brazil.


Control in clinical trials is a cornerstone of medical research in Brazil. The country’s robust regulatory bodies, such as ANVISA, ensure compliance with national regulations and international guidelines, safeguarding the integrity and ethical conduct of clinical trials.

Participant recruitment strategies prioritize diversity and transparency, ensuring that trials represent a broad population. Rigorous data monitoring processes guarantee the accuracy and reliability of trial outcomes, enhancing the credibility of medical research in Brazil.

Brazil’s commitment to maintaining high standards of control in clinical trials has positioned it as a leading destination for medical research. By upholding stringent control measures and ethical standards, Brazil continues to contribute to the advancement of medical knowledge and the improvement of patient care on both a national and global scale.


Control in Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Control in Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Control in Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Control in Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Control in Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Control in Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Control in Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Control in Clinical Trials in Brazil

The Cohortias Team

Control in Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Control in Clinical Trials in Brazil

Network & Partnerships